Clinical trials

  • BL-B01D1 for Non-small cell lung cancer|Other solid tumors
  • Pembrolizumab for Renal cell carcinoma|Metastatic renal cell carcinoma
  • RO7269162 for Prodromal Alzheimer's disease | Alzheimer's disease
  • BIMEKIZUMAB for Psoriatic arthritis
  • INAVOLISIB for Hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer with PIK3CA mutation
  • Adeno-associated virus serotype RH79 containing the human OTC gene for Ornithine transcarbamylase deficiency (OTC)
  • obinutuzumab for Primary membranous nephropathy|Membranous nephropathy
  • Baricitinib for Uveitis | Juvenile idiopathic arthritis-associated uveitis | Chronic anterior antinuclear antibody-positive uveitis
  • Camellia sinensis (green tea) leaf extract for Anal high-grade squamous intraepithelial lesion (anal HSIL)
  • METHYL (E,6S)-7-[[1-[2-(2-ETHYLBUTYLAMINO)-2-OXOETHYL]-2-OXOPYRIDIN-3-YL]AMINO]-6-[(3-METHYLIMIDAZOLE-4-CARBONYL)AMINO]-7-OXOHEPT-2-ENOATE for Celiac disease
  • CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS for Lower limb spasticity|Post-stroke spasticity|Traumatic brain injury-related spasticity
  • CETRELIMAB for Advanced solid tumors